Leis D, Braun S
Arch Gynecol. 1981;230(3):225-30. doi: 10.1007/BF02111807.
Fourteen women, 18--46 years old (median age: 28 years) with hypergonadotrophic ovarian failure were each treated daily for 21 days with 10 micrograms, 20 micrograms, 40 micrograms, and 60 micrograms ethinyl estradiol, 2,000 micrograms estriol, and 1,250 micrograms conjugated estrogens in six or more consecutive treatment cycles in a randomly assigned sequences. Before treatment and at the beginning of the 3rd week of each of the mentioned estrogen regimens, basal serum FSH and LH levels were measured. During the last 5 days of each treatment cycle, 10 mg of oral norethisterone acetate were given in addition to the estrogen, and after a treatment-free interval of 7 days the next estrogen regimen was begun according to the random list. FSH values were inversely related to the various dosages of ethinyl estradiol; the upper normal range with the exception of the periovulatory phase was reached with 40--60 micrograms ethinyl estradiol. FSH levels during treatment with 1250 micrograms of conjugated estrogens were similar to those found during treatment with 20 micrograms ethinyl estradiol. When 2,000 micrograms of estriol were given daily, FSH levels rose of pretreatment values. LH behaved similarly except that during treatment with 2,000 micrograms of estriol and 10 micrograms of ethinyl estradiol values above pretreatment levels were found.
14名年龄在18 - 46岁(中位年龄:28岁)的高促性腺激素性卵巢功能衰竭女性,按照随机分配的顺序,在六个或更多连续治疗周期中,每天分别接受10微克、20微克、40微克和60微克乙炔雌二醇、2000微克雌三醇和1250微克结合雌激素治疗21天。在治疗前以及上述每种雌激素治疗方案的第3周开始时,测量基础血清促卵泡生成素(FSH)和促黄体生成素(LH)水平。在每个治疗周期的最后5天,除雌激素外,加用10毫克口服醋酸炔诺酮,在7天的无治疗间隔期后,根据随机列表开始下一个雌激素治疗方案。FSH值与乙炔雌二醇的不同剂量呈负相关;除排卵期外,40 - 60微克乙炔雌二醇可达到正常上限范围。使用1250微克结合雌激素治疗期间的FSH水平与使用20微克乙炔雌二醇治疗期间的水平相似。当每天给予2000微克雌三醇时,FSH水平高于治疗前值。LH的表现类似,只是在给予2000微克雌三醇和10微克乙炔雌二醇治疗期间,发现其值高于治疗前水平。